Article Details
Retrieved on: 2022-01-26 11:12:08
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
On Tuesday, Pfizer announced it is starting a clinical study to evaluate the safety, tolerability and immunogenicity of an omicron-based vaccine ...
Article found on: www.abcactionnews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here